Please login to the form below

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?

We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also highlighted some pretty big issues in clinical research. For example, the world can see how the BAME community has been disproportionately affected by the coronavirus, which has also underlined how unrepresentative clinical trials are of them. And over the last few weeks, we’ve been looking at other populations who are also being left behind.

The LGBTQ+ community have faced a history of marginalisation in clinical trials, leading to challenges and barriers that still deter them from taking part. According to research from the LGBT Foundation, LGBTQ+ people are:

  • Less likely to access healthcare when they need it
  • More likely to be living with HIV
  • More likely to be homeless or insecurely housed
  • More likely to smoke
  • Less likely to be physically active or have a good diet

And as we began to look into the relationship between the LGBTQ+ community and clinical trials via social listening, we’ve seen that individuals face poorer health outcomes as a result of COVID-19…

Insights into the LGBTQ+ community and clinical trials

Of all the online content that we audited, we found it shocking that only 2% was positive, while the other 98% was neutral or negative. Just to give you an idea of what we mean, the most frequently occurring keywords associated with terms like ‘LGBTQ+’ and ‘clinical trials’ are predominantly negative and medical terms such as: “Undiagnosed HIV infection” and “Heart disease risk” - as well as talk around key evidence gaps, donor eligibility and lifestyle factors including diet, alcohol and recent sex.

Traditionally, members of the LGBTQ+ community have been seen as hard‐to‐reach populations for clinical trial recruitment due to historical stigmatisation. Only a decade ago, a review of the inclusion criteria in clinical trials indicated that exclusion of lesbians and gay men from clinical trials in the US isn’t uncommon, particularly in studies with sexual function as an end point. And another study found women were underrepresented in research in 7 out of the 11 disease categories, even when women were more likely to have the disease.

Fast forward to 2020, and COVID-19 clinical trial guidelines are being called out as demonstrating “archaic and homophobic rules” that prevent gay and bisexual men from participating due to blood and plasma donation guidance.

In light of this, our social listening report looks deeper into how LGBTQ+ people still face discrimination and stark health inequalities rooted in historical preconceptions. Plus, we highlight how clinical research will need to address these issues during and following the COVID-19 pandemic.

You can read the full report here:

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

13th July 2020

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert Simon, a American Nobel Laureate scientist, speak extensively about how emotions can influence, skew and determine the outcome of so many decisions we’re confronted with every day.
COUCH Health
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the overall study design must be company driven. There’s still opportunity to get creative and get and even better, get patients involved with design. And there’s big benefits of doing this, too!
COUCH Health
Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design.
COUCH Health
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment.
COUCH Health
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest initiatives that are trying to create positive change.
COUCH Health
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people, while catching up on the latest in the industry. Here, we’ve highlighted some of the discussions that really stood out or resonated with us at COUCH Health, which you might find interesting too. Enjoy!
COUCH Health